ArticleThe journal of international advanced otology2024
Effect of Age on Distortion Product Otoacoustic Emissions at Extended High Frequencies.
Article in The journal of international advanced otology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The inner ear is most susceptible to the aging effects. Distortion product otoacoustic emissions (DPOAEs) are a good indicator for interpreting the age effects but are usually recorded at up to 8000 Hz frequencies in routine audiologic testing. The present study was designed to assess and compare the DPOAEs at conventional frequencies and at extended high frequencies (EHFs) across different age groups. Extended high-frequency audiometry (9000-16000 Hz) and DPOAEs from 500-16000 Hz were recorded on 80 adult (160 ears) participants (15-55 years) with normal hearing sensitivity. The participants were categorized into 4 groups: group I (15-<25 years), group II (25-<35 years), group III (35-<45 years), and group IV (45-55 years). A statistically significant reduction in EHF thresholds was observed from group III onward. However, the thresholds were comparatively better for group III at frequencies 9000, 10000, and 11500Hz than group IV. No significant difference was observed for EHF DPOAEs in groups I and II (except at 16000 Hz) and III and IV. Distortion product otoacoustic emissions at conventional frequencies in group IV were significantly poorer than the other 3 groups. A weak negative correlation was observed between the DPOAE parameters and EHF thresholds. The effect of age was more pronounced on EHF DPOAEs than EHF thresholds for frequencies 9000, 10000, and 11500 Hz. Distortion product otoacoustic emissions at EHF started deteriorating below the age of 30 years and showed a rapid decline above 35 years. Extended high-frequency DPOAEs can be used as screening tools to assess the function of the basal part of the cochlea.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.